---
type: "Symbol"
title: "Belite Bio (BLTE.US) — Community Discussions"
description: "Community discussions about this stock, including analyst opinions, earnings analysis, and investment strategies from verified financial professionals and active investors."
locale: "en"
url: "https://longbridge.com/en/quote/BLTE.US/topics.md"
symbol: "BLTE.US"
parent: "https://longbridge.com/en/quote/BLTE.US.md"
count: 2
datetime: "2026-03-12T00:26:06.754Z"
locales:
  - [en](https://longbridge.com/en/quote/BLTE.US/topics.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BLTE.US/topics.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BLTE.US/topics.md)
---

# Belite Bio (BLTE.US) — Community Discussions

### [$Pharmaceuticals(IN00372.US)So miserable…🥲🥲🥲😢�…](https://longbridge.com/en/topics/30983134.md)

- Author: [Fifty_Gulag](https://longbridge.com/en/profiles/15598476.md)
- Datetime: 2025-06-23T05:07:46.000Z
- Comments: 0
- $Pharmaceuticals(IN00372.US)So miserable…🥲🥲🥲😢😢😢

### [【新股 IPO】BLTE：专注于眼部疾病的药物开发公司，在二级市场具有优秀表现](https://longbridge.com/en/topics/3027694.md)

- Author: [阿浦美股](https://longbridge.com/en/profiles/6844605.md)
- Datetime: 2022-07-03T06:35:47.000Z
- Comments: 1
- 01 企业介绍 BLTE$Belite Bio(BLTE.US) 是一家临床阶段的生物制药药物开发公司，专注于针对目前无法治愈的眼部疾病的新疗法，这些疾病涉及视网膜变性，例如萎缩性年龄相关性黄斑变性（通常称为干性 AMD）和常染色体隐性 Stargardt 病，或 STGD1，这两种疾病都逐渐领先永久性失明和代谢疾病...

**Comments:**

- **m8ezwq · 2022-07-03T10:15:06.000Z**: 無特別留意開 謝謝介紹

## References

- [Belite Bio (BLTE.US)](https://longbridge.com/en/quote/BLTE.US.md)


> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/BLTE.US/topics.md) | [繁體中文](https://longbridge.com/zh-HK/quote/BLTE.US/topics.md)